Bleeding Disorders

MD IQ

Board Review Questions

Transfusion Reactions (part 2)

Commentary

A new era of TTP treatment

Many questions remain following the FDA’s approval of caplacizumab, specifically, which patients should receive it. The high cost of the drug is...

Board Review Questions

Transfusion Reactions (part 1)

Pages